FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Sufentanil Citrate Injection
Status: Currently in Shortage
»Date first posted: 05/03/2022
»Therapeutic Categories: Analgesia/Addiction; Pediatric

Expand all

Akorn Pharmaceuticals (Revised 05/04/2022)

Company Contact Information:
800-932-5676

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
50 mcg/mL (NDC 17478-050-01), 1mL vial, 10 pack On backorder Estimated recovery Dec 2022 Availability of API
50 mcg/mL (NDC 17478-050-02), 2mL vial, 10 pack On backorder Estimated recovery Dec 2022 Availability of API
50 mcg/mL (NDC 17478-050-05), 5mL vial, 10 pack On backorder Estimated recovery Dec 2022 Availability of API

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (New 05/03/2022)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Information pending Information pending Information pending

Hospira, Inc. (Reverified 05/10/2022)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
50 mcg/mL Single Dose Glass Fliptop Vial (NDC 0409-3382-21) Next Delivery and Estimated Recovery: March 2023 Shortage per Manufacturer: Manufacturing Delay Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English